7 Adrenergic agonists do not compete with the antagonist (−)3-[125I]iodocyanopindolol for binding to rat pleural or peritoneal mast cell adrenergic receptor

8 consistent association between beta dna element and transfer rna genes in candida albicans

9 la forma aristotélica y la solución de las aporías del libro beta

10 risk analysis of investments in mutual funds

11 refining our understanding of beta through quantile regressions

12 abnormal task modulation of oscillatory neural activity in schizophrenia

13 theta and beta oscillatory dynamics in the dentate gyrus reveal a shift in network processing state during cue encounters

14 acceptance towards giving birth to a child with beta-thalassemia major – a prospective study

15 The use of cosmic-ray muons in the energy calibration of the Beta-decay Paul Trap silicon-detector array

16 Characterization of cubic Li$$_{2}$$$$^{100}$$MoO$$_4$$ crystals for the CUPID experiment

17 Beneficial effects of lysosome-modulating and other pharmacological and nanocarrier agents on amyloid-beta-treated cells.

18 Selective two-step synthesis of 2,5-diformylfuran from monosaccharide, disaccharide, and polysaccharide using H-Beta and octahedral MnO<inf>2</inf> molecular sieves

19 Synthesis and characterization of composite molecular sieves comprising zeolite Beta with MCM-41 structures

20 Silver nanoparticle modulates the aggregation of beta-lactoglobulin and induces to form rod-like aggregates

21 EI-2346, a novel interleukin-1beta converting enzyme inhibitor produced by Streptomyces sp. E-2346. I. Taxonomy of producing strain, fermentation, isolation, physico-chemical properties, and biological properties.

22 Cyrmenins, new beta-methoxyacrylate inhibitors of the electron transport. Production, isolation, physico-chemical and biological properties.

23 EI-1941-1 and -2, novel interleukin-1 beta converting enzyme inhibitors Produced by Farrowia sp. E-1941. II. Taxonomy of producing strain, fermentation, isolation, physico-chemical properties, and biological properties.

24 Truncated carboxyl-terminal fragments of beta-amyloid precursor protein are processed to amyloid beta-proteins 40 and 42.

25 Beneficial effects of lysosome-modulating and other pharmacological and nanocarrier agents on amyloid-beta-treated cells.

26 Beta-Glucan as Wall Material in Encapsulation of Elderberry (Sambucus nigra) Extract.

27 Facile synthesis of chitosan-grafted beta-cyclodextrin for stimuli-responsive drug delivery.

28 [Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: Risk factors and key preventive measures for eradication in record time].

29 Design of Ti-Beta zeolites with high Ti loading and tuning of their hydrophobic/hydrophilic character

30 Novel iminobenzoxathiolone compound inhibits nuclear factor-kappaB activation targeting inhibitory kappaB kinase beta and down-regulating interleukin-1beta expression in lipopolysaccharide-activated macrophages.

31 Crystalization and preliminary X-ray crystallographic analysis of the laminarinase endo-beta-1,3-glucanase from Pyrococcus furiosus.

32 Is it difficult to obtain inter-observer agreement in the measurement of the beta angle in ultrasound evaluation of the paediatric hip?

33 Failure of puberty and linear growth in beta-thalassemia major.

34 “King” Godan: Status of the Ruling Chinggisid in Mongolian and Tibetan Sources

35 A Protein-Linger Strategy Keeps the Plant On-Hold After Rehydration of Drought-Stressed Beta vulgaris

36 Evidence for estrogen receptor beta-selective activity of Vitex agnus-castus and isolated flavones.

37 Transforming growth factor beta 1 polymorphisms and haplotypes associated with breast cancer susceptibility: A case-control study in Tunisian women.

38 Preparation of monometallic and bimetallic alloy nanoparticles stabilized with sulfobetaine-based block copolymer and their catalytic activities

39 PENDUGAAN KANDUNGAN BETA KAROTEN IKAN LOMPA (Thryssa baelama) DI PERAIRAN PANTAI APUI, MALUKU TENGAH

40 Gini Katsayısını Etkileyen Faktörlerin Beta Regresyon Yöntemi Yardımı ile Belirlenmesi

41 Beta Glucosidase Recognition By Imprinted Polyacrylamide Hydrogels

42 Multilocus sequence typing and blaESBL characterization of extended-spectrum beta-lactamase-producing Escherichia coli isolated from healthy humans and swine in Northern Thailand

43 Antimicrobial resistance pattern and molecular genetic distribution of metallo-β-lactamases producing Pseudomonas aeruginosa isolated from hospitals in Minia, Egypt

44 Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae

45 Phenotypic and genotypic characterization of multi-drug-resistant Escherichia coli isolates harboring blaCTX-M group extended-spectrum β-lactamases recovered from pediatric patients in Shenzhen, southern China

46 Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort

47 Simulating moxalactam dosage for extended-spectrum β-lactamase-producing Enterobacteriaceae using blood antimicrobial surveillance network data

48 Association of the genes encoding Metallo-β-Lactamase with the presence of integrons among multidrug-resistant clinical isolates of Acinetobacter baumannii

49 Prevalence and risk factors for colonization by extended-spectrum β-lactamase-producing or ST 131 Escherichia coli among asymptomatic adults in community settings in Southern Taiwan

50 High rates of CTX-M group-1 extended-spectrum β-lactamases producing Escherichia coli from pets and their owners in Faisalabad, Pakistan

51 New Delhi metallo-β-lactamase-producing Acinetobacter isolates among late-onset VAP patients: multidrug-resistant pathogen and poor outcome

52 Emergence and molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates harboring blaCTX-M-15 extended-spectrum β-lactamases causing ventilator-associated pneumonia in China

53 Performance evaluation of the (1,3)-β-D-glucan detection assay in non-intensive care unit adult patients

54 Phenotypic and genotypic characterizations of extended-spectrum beta-lactamase-producing Escherichia coli in Thailand

55 Effectiveness of empiric aztreonam compared to other beta-lactams for treatment of Pseudomonas aeruginosa infections

56 Epidemiology of and risk factors for infection with extended-spectrum β-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case–control study

57 Antibiotic resistance pattern and molecular characterization of extended-spectrum β-lactamase producing enteroaggregative Escherichia coli isolates in children from southwest Iran

58 Epidemiology and molecular characterization of multidrug-resistant Escherichia coli isolates harboring blaCTX-M group 1 extended-spectrum β-lactamases causing bacteremia and urinary tract infection in Manhiça, Mozambique

59 Moxalactam is not more active on extended spectrum β-lactamase (ESBL) producing bacteria than on non-ESBL producers

60 Carriage of colistin-resistant, extended-spectrum β-lactamase-producing Escherichia coli harboring the mcr-1 resistance gene after short-term international travel to Vietnam

61 Antibacterial effect evaluation of moxalactam against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae with in vitro pharmacokinetics/pharmacodynamics simulation

62 Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children

63 Extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae among Ethiopian children

64 Occurrence of extended-spectrum and AmpC β-lactamases in multiple drug resistant Salmonella isolates from clinical samples in Lagos, Nigeria

65 Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics

66 blaCTX-M-I group extended spectrum beta lactamase-producing Salmonella typhi from hospitalized patients in Lagos, Nigeria

67 Wide dissemination of extended-spectrum β-lactamase-producing Escherichia coli in community residents in the Indochinese peninsula

68 Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection

69 The β-lactamase inhibitor avibactam (NXL104) does not induce ampC β -lactamase in Enterobacter cloacae

70 Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination

71 Risk factors for infections with extended- spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden

72 Fecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in nursing homes in the Kinki region of Japan

73 Prevalence of extended-spectrum beta-lactamase-producing bacteria in food

74 High prevalence of extended-spectrum β-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India

75 Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance

76 Guideline-recommended therapy, including beta-blocker utilization, in patients with chronic heart failure: results from a Canadian community hospital heart function clinic

77 Association of the genes encoding Metallo-β-Lactamase with the presence of integrons among multidrug-resistant clinical isolates of Acinetobacter baumannii

78 Gini Katsayısını Etkileyen Faktörlerin Beta Regresyon Yöntemi Yardımı ile Belirlenmesi

79 Beta Glucosidase Recognition By Imprinted Polyacrylamide Hydrogels

80 Multilocus sequence typing and blaESBL characterization of extended-spectrum beta-lactamase-producing Escherichia coli isolated from healthy humans and swine in Northern Thailand

81 Antimicrobial resistance pattern and molecular genetic distribution of metallo-β-lactamases producing Pseudomonas aeruginosa isolated from hospitals in Minia, Egypt

82 Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae

83 Gini Katsayısını Etkileyen Faktörlerin Beta Regresyon Yöntemi Yardımı ile Belirlenmesi

84 Beta Glucosidase Recognition By Imprinted Polyacrylamide Hydrogels

85 Multilocus sequence typing and blaESBL characterization of extended-spectrum beta-lactamase-producing Escherichia coli isolated from healthy humans and swine in Northern Thailand

86 Antimicrobial resistance pattern and molecular genetic distribution of metallo-β-lactamases producing Pseudomonas aeruginosa isolated from hospitals in Minia, Egypt

87 Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae

88 Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Meningitis and Cerebral Abscess in a Neonate: Therapeutic Challenge

89 Phenotypic and genotypic characterization of multi-drug-resistant Escherichia coli isolates harboring blaCTX-M group extended-spectrum β-lactamases recovered from pediatric patients in Shenzhen, southern China

90 Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort

91 Simulating moxalactam dosage for extended-spectrum β-lactamase-producing Enterobacteriaceae using blood antimicrobial surveillance network data

92 Association of the genes encoding Metallo-β-Lactamase with the presence of integrons among multidrug-resistant clinical isolates of Acinetobacter baumannii

93 Prevalence and risk factors for colonization by extended-spectrum β-lactamase-producing or ST 131 Escherichia coli among asymptomatic adults in community settings in Southern Taiwan

94 High rates of CTX-M group-1 extended-spectrum β-lactamases producing Escherichia coli from pets and their owners in Faisalabad, Pakistan

95 New Delhi metallo-β-lactamase-producing Acinetobacter isolates among late-onset VAP patients: multidrug-resistant pathogen and poor outcome

96 Emergence and molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates harboring blaCTX-M-15 extended-spectrum β-lactamases causing ventilator-associated pneumonia in China

97 Performance evaluation of the (1,3)-β-D-glucan detection assay in non-intensive care unit adult patients

98 Phenotypic and genotypic characterizations of extended-spectrum beta-lactamase-producing Escherichia coli in Thailand

99 Effectiveness of empiric aztreonam compared to other beta-lactams for treatment of Pseudomonas aeruginosa infections

100 Epidemiology of and risk factors for infection with extended-spectrum β-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case–control study

101 Antibiotic resistance pattern and molecular characterization of extended-spectrum β-lactamase producing enteroaggregative Escherichia coli isolates in children from southwest Iran

Keyword Connections

Journals

Research Groups

Bibliographies